The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).
These are the guidelines for the registration, renewal, change in characteristics and extension in range of both imported and locally manufactured registered pharmaceutical products.
Clinical Trials Act
This Act regulates the conduct of clinical trials for medicinal products in Mauritius.
Dangerous Drug Act
This Act provides for the regulation, control and classification of dangerous drugs.
This Act regulates the practice of pharmacy in the country, establishes guidelines for the licensing, operation, and conduct of pharmacies, as well as regulates the sale and manufacture of pharmaceutical products.